Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

FDA reviews Wyeth-Ayerst combination vaccine

March 24, 1997

Immunostimulants from Takeda

March 21, 1997

Glaxo Wellcome licenses HSV vaccine

March 20, 1997

Antex Biologics reports on Campylobacter vaccine trial

March 20, 1997

Peptech awarded grant for development of GMDP

March 20, 1997

Maxim notified of patent allowance for MaxVax technology

March 20, 1997

Pharmacokinetic model described for BMS-188667

March 18, 1997

First live oral cholera vaccine approved in Canada

March 13, 1997

Activated immunoglobulins reported by Nippon Zoki

March 12, 1997

Positive preliminary results for rotavirus vaccine

March 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.